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Abstract
Background: Despite the non-invasive nature of non-invasive prenatal testing (NIPT), there is still a need for a
separate informed consent process before testing. The objectives of this study are to assess (a) knowledge and
preferences of Chinese women in a major public hospital in Hong Kong who underwent NIPT, and (b) whether
their knowledge and preferences differ depending on womens’ characteristics and sources of information.
Methods: Setting: prenatal diagnosis and counselling clinic.
Between February 2012 and September 2013, a questionnaire survey was distributed to all women who underwent
NIPT after positive aneuploidy screening. As a pilot study, ten knowledge questions were designed based on the
rapid response statement on Prenatal Detection of Down Syndrome using Massively Parallel Sequencing from the
International Society for Prenatal Diagnosis in 2011. The source of women’s knowledge and their preferences were
also evaluated. While conventional screening was publicly funded, NIPT was not. Differences between subgroups
were compared using chi square tests and logistic regression analysis.
Results: Of 152 women who underwent NIPT, 135 (88.8 %) completed their questionnaires. More than 90 % of
women recognised the possibility of false positive and false negative results. Slightly more than 70 % of women
knew the inferior sensitivity of NIPT compared to an invasive test, and the possibility of an uninformative test result,
but were not aware of the complicated aspects of NIPT. Pregnant women with an advanced level of education or
those who underwent NIPT before 15 weeks provided answers that was more accurate by around 10-20 % in two
to three knowledge questions than those without. These associations were confirmed by multivariate logistic
regression analysis. The women received information on NIPT largely from their private doctors (47.4 %) and web
(41.5 %). In their future pregnancies, more women would opt for NIPT (a self-financed item) after positive screening
(‘free’ in a public hospital) (57.8 %) than as a primary screening (30.4 %).
Conclusions: It is feasible to use a questionnaire based on the ISPD statement on NIPT to assess women’s
knowledge of the test. The Chinese women who underwent NIPT recognised the limitations, but did not
understand the complicated aspects. More information should be provided by health care professionals in order to
facilitate an informed choice by patients. More women preferred NIPT as a contingent test than as a primary
screening probably because of its high cost.
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Background
Among various prenatal screening methods for Down
syndrome, non-invasive prenatal testing (NIPT), a new
technology assessing cell-free fetal DNA (cffDNA) in
maternal blood, is the most sensitive and specific one
[1–8]. Its recent introduction resulted in a marked decline
in the number of invasive procedures [9–13], and conven-
tional screening [10–12], even in the first year of its avail-
ability. NIPT is well accepted by women [10, 11, 13, 14]
and offered by obstetricians [15].
Despite the non-invasive nature of NIPT, both preg-
nant women [16] and genetic counsellors [17] regard
that there is still a need for a separate informed consent
process before testing. Major governing or professional
bodies including the American College of Obstetricians
and Gynecologists, the American College of Medical Gen-
etics, National Society of Genetic Counselors (NSGC), and
International Society for Prenatal Diagnosis (ISPD) recom-
mend offering NIPT in the context of informed consent,
education and counselling [18–21]. Whether women are
given adequate information before making an informed de-
cision for NIPT is not known. Besides, whether a previous
history of NIPT affects women’s preference for NIPT in the
future pregnancy is also not known. NIPT was introduced
in Hong Kong in August 2011. Few studies have been
conducted on women’s knowledge and preferences. The
objectives of this study are to assess (a) knowledge and
preferences of Chinese women in a major public hos-
pital in Hong Kong who underwent NIPT, and (b)
whether their knowledge and preferences differ depending
on their characteristics and sources of information.
Methods
Between February 2012 and September 2013, we invited
all Chinese pregnant women who underwent NIPT for a
positive conventional aneuploidy screening to complete
a questionnaire in the setting of our prenatal diagnosis
and counselling clinic. All included women underwent
Down syndrome screening at our clinic. Screen-positive
women who underwent NIPT were followed up for
counselling and a mid-trimester anomaly scan during
which the questionnaire was completed. Our hospital is
one of the largest public hospitals in Hong Kong, with
more than 6,000 deliveries a year. Multiple pregnancies
were excluded. The study protocol was approved by the
Research Ethics Committee (Kowloon Central/Kowloon
East), Hospital Authority, Hong Kong. This research
project conforms to the provisions of the Declaration of
Helsinki. Informed consent was obtained from every
participant in this study.
Options for prenatal testing for Down syndrome
Since 1 July 2010, universal prenatal screening for Down
syndrome has been offered to all pregnant women after
adequate counselling irrespective of maternal age. The
options included first trimester combined (based on nu-
chal translucency, pregnancy-associated plasma protein
A (PAPP-A) and free beta human chorionic gonado-
tropin (beta hCG)), or second trimester maternal serum
screening (based on alpha fetoprotein and total beta
hCG) depending on the week of gestation at the time of
booking. All counselling on screen-positive women were
conducted or supervised by a maternal and fetal medi-
cine subspecialist, and different options including an in-
vasive test or no further testing were discussed. Since
August 2011, NIPT has been available in the private sec-
tor in Hong Kong, and this option was also discussed as
an alternative to an invasive test with screen-positive
women in our clinic upon questioning. Most commercial
NIPT tests during the study period were based on mas-
sively parallel sequencing with ‘shortgun’ counting of all
cell-free DNA sequences, while the remaining used ‘tar-
geted’ counting of specific DNA sequences. An informa-
tion sheet on NIPT including the process, benefits and
limitations was provided. After undergoing NIPT with
separate counselling provided by private obstetricians,
women were followed up, rescanned for fetal structures,
counselling on the NIPT result, and offered a free option
of invasive testing after a positive NIPT result or for
other reasons. As a pilot study, a questionnaire was de-
signed to assess the quality of counselling that we provided.
Questionnaire on knowledge and preference
The questionnaire was designed to assess women’s char-
acteristics, knowledge on NIPT and preference in future
pregnancies. Demographic factors including age, gravid-
ity, parity, method of conception, education, employ-
ment, and gestational week whilst undergoing NIPT
were collected. There were ten knowledge questions
based on the rapid response statement on Prenatal
Detection of Down Syndrome using Massively Parallel
Sequencing from a committee on behalf of the Board of
the International Society for Prenatal Diagnosis (ISPD)
in October 201117 (Table 2). The source (doctor, web,
books, colleagues, friends or others) of their knowledge
on NIPT was also assessed. The questionnaire was
printed, distributed to the women in our prenatal diag-
nosis and counselling clinic and completed by them with
the assistance of an experienced midwife if required, to
explain medical terms or general terms in a straightfor-
ward manner if Cantonese was not their mother tongue.
Statistical analysis
With the use of descriptive statistics, the proportions of
respondents selecting each answer to questions on the
knowledge and preference were presented. Their answers
on knowledge questions were then recorded as correct or
incorrect. We analysed whether their knowledge and
Kou et al. BMC Pregnancy and Childbirth  (2015) 15:199 Page 2 of 7
preference on NIPT vary with demographic factors and
source of information using chi square test and logistic re-
gression with backward stepwise (likelihood ratio) analysis.
All statistical analysis was performed using SPSS 16.0 for
Windows.
Results
Between August 2011 and July 2013, 152 women
underwent NIPT. The results and impact on the num-
ber of invasive testing were presented previously [13].
Two of them underwent invasive testing because of
high-risk results for trisomy 21 or trisomy 18, and all
positive results were confirmed. One woman under-
went amniocentesis despite low-risk result for aneuploidy,
and had a normal karyotype. All babies screened to be low
risk by NIPT were confirmed normal after birth on physical
examination.
Of these 152 women, 135 (88.8 %) completed the
questionnaire. There were no differences in the charac-
teristics between the respondents and non-respondents
(Table 1). All 135 women filled out the questionnaire
after learning the results of their NIPT. The mean
interval between NIPT and questionnaire was 30.0 days.
Of these 135 women who completed the questionnaire,
63.7 % were aged 35 or above, 91.1 % conceived natur-
ally, 60.7 % were nulliparous, 66.7 % had a tertiary edu-
cation or higher, and 86.7 % were employed (Table 1).
Women’s knowledge on NIPT
More than 90 % of women recognised the potential for
false positive and false negative results of NIPT for
Down syndrome (Questions 2 and 3, Table 2). Around
95.6 % of women understood it would be very stressful if
NIPT showed a positive result (Question 4, Table 2).
More than 70 % of women recognised the inferior sensi-
tivity of NIPT for the detection of chromosomal abnor-
malities compared to an invasive test, and additionally
recognised the possibility of uninformative test results
(Questions 1 and 5, Table 2).
For the knowledge questions on NIPT’s applicability to
special at-risk groups (Questions 6–10, Table 2), about
half of the women answered ‘do not know’ and less than
10 % answered correctly (marked a in Table 2). So, fur-
ther analysis by stratification was not performed on an-
swers to questions 6–10.
Women’s knowledge and characteristics and information
The women received information on NIPT largely from
their private doctors (47.4 %), web (41.5 %), relatives/
friends (23.0 %), but little from their colleagues (3.0 %),
books or magazines (0.7 %), or other means (5.2 %).
Twenty-nine women (21.5 %) received information from
more than one source.
Pregnant women who underwent NIPT before 15 weeks
of gestation had significantly higher proportions of correct
answers to three knowledge questions on NIPT with odds
ratios of 6.2, 3.4 and 5.6 in Questions 2, 3 and 4 respect-
ively than those after 15 weeks (Table 3). Besides, pregnant
women with an advanced level of education had signifi-
cantly higher proportions of correct answers in two know-
ledge questions on NIPT with odds ratios of 5.6 and 13.6
in Questions 2 and 4 respectively than those without
(Table 3).
There were no significant differences in the proportions
of correct answers to questions 1 to 5 according to their
characteristics (including advanced maternal age, parity,
history of miscarriage or termination of pregnancy,
method of conception, status of employment) or source of
information (including private doctors, web, relatives/
friends, colleagues, books or magazines, and other means).
Women’s preference
Significantly more women preferred NIPT as a contin-
gency test than as a primary screening test in future
pregnancies (57.8 % vs 30.4 %, p < 0.001). Subgroup ana-
lysis revealed no significant differences in preferences
among women with different characteristics or different
sources of information (as above).
Discussion
In the present study, the majority (>90 %) of pregnant
women recognised the possibilities of false negative and
Table 1 Socio-demographic and obstetric characteristics of the









86 (63.7 %) 8 (50.0 %) 0.415
Parity
0 82 (60.7) 9 (56.3 %) 0.685
1 49 (36.3 %) 7 (43.7 %)
2 4 (3.0 %) 0 (0 %)
Previous miscarriage or
termination of pregnancy
0 83 (61.5 %) 9 (56.3 %) 0.107
1 40 (29.6 %) 5 (31.3 %)
2 or above 12 (8.9 %) 2 (12.5 %)
Conceived naturally 123 (91.1 %) 16 (100 %) 0.366
Advanced education
(tertiary education or above)
90 (66.7 %) 14 (87.5 %) 0.15
Employed 117 (86.7 %) 13 (81.3 %) 0.466
Underwent NIPT before
15 weeks
132 (97.8 %) 14 (87.5 %) 0.086
aone missing data
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false positive results of NIPT, while more than 70 % of
them recognised its limited sensitivity of detecting uncom-
mon aneuploidies compared with an invasive test, and the
possibility of uninformative test results. Only a small pro-
portion (<10 %) of women answered correctly to questions
on the applicability of NIPT in special groups of pregnant
women. We did not identify any similar studies for com-
parisons. However, our findings are in accordance with
previous studies that pregnant women generally know
more about practical aspects of Down syndrome than
screening limitations and accuracy [22, 23].
Pregnant women with an advanced level of education
had higher proportions of correct answers in two know-
ledge questions on NIPT than those without. This find-
ing is consistent with previous studies that education
level predicted knowledge level on conventional screen-
ing for Down syndrome [24–26]. In addition, pregnant
women who underwent NIPT before 15 weeks of gesta-
tion had higher proportions of correct answers in two
knowledge questions on NIPT than those after 15 weeks.
This result is not unexpected, as first-trimester screening
is associated with the use of NIPT [13, 27]. We postulate
that women with an earlier NIPT are more willing to
know more about the test. Although Nullipara and
employed women are associated with the use of NIPT,
our present study did not show that these subgroups of
women knew more about NIPT than Multipara and the
unemployed. It seems that the need for adequate pre-
test counselling of women is not limited to particular
subgroups [28].
Table 2 Responses of women to ten knowledge questions and two preferences questions on non-invasive prenatal testing (NIPT)
(n = 135)
Questions Yes No Do not know
1. NIPT can detect only half of the fetal chromosomal abnormalities
that would be identified through amniocentesis or chorionic villus sampling
101 (74.8 %)a 13 (9.6 %) 21 (15.6 %)
2. NIPT does not detect all cases of fetal Down syndrome 124 (91.9 %)a 3 (2.2 %) 8 (5.9 %)
3. There are also occasional false-positive results and therefore women
with positive NIPT results need to receive confirmatory testing through
chorionic villus sampling or an amniocentesis
122 (90.4 %)a 5 (3.7 %) 8 (5.9 %)
4. Women with positive NIPT results are at very high risk of Down syndrome
and for some women the extended period awaiting confirmatory invasive testing
results is likely to be highly stressful
129 (95.6 %)a 1 (0.7 %) 5 (3.7 %)
5. For some women, a NIPT test result may not be informative because of inadequate
amount of fetal DNA in maternal plasma or other reasons
97 (71.9 %)a 3 (2.2 %) 35 (25.9 %)
6. NIPT is suitable for those women who have or with a family history of a chromosomal
abnormality carrying an increased risk of inheritance to their child
65 (48.2 %) 6 (4.4 %)a 64 (47.4 %)
7. NIPT is suitable for multiple pregnancies 73 (54.1 %) 7 (5.2 %)a 55 (40.7 %)
8. NIPT is suitable for pregnancies conceived after donor in vitro fertilization 56 (41.5 %) 3 (2.2 %)a 76 (56.3 %)
9. NIPT is suitable to detect fetal single gene disorder such as thalassemia 58 (43.0 %) 5 (3.7 %)a 72 (53.3 %)
10. NIPT is suitable for those women who recently received blood transfusion, organ
transplant or stem cell therapy
55 (40.7 %) 7 (5.2 %)a 73 (54.1 %)
11. In your next pregnancy, you will opt for a conventional screening test for
Down syndrome first and then, if screened high risk, will opt for a NIPT.
78 (57.8 %) 38 (28.1 %) 19 (14.1 %)
12. In your next pregnancy, you will opt for NIPT directly without undergoing a
conventional screening test for Down syndrome.
41 (30.4 %) 73 (54.1 %) 21 (15.5 %)
Questions 1 to 10 were the ten knowledge questions developed on the basis of the rapid response statement of the Board of the International Society for
Prenatal Diagnosis. Correct answers were marked as a
Table 3 Proportions and adjusted odds ratios (OR) of correct answers to the first five knowledge questions: comparing non-invasive
prenatal testing (NIPT) before 15 weeks versus after 15 weeks and with advanced education versus without
NIPT before 15 weeks Advanced education
Questions Yes (%) No (%) P value OR (95 % CI) Yes (%) No (%) P value OR (95 % CI)
1. Comparison with invasive test 71.5 62.5 0.125 2.1 (0.8–5.3) 77.8 68.9 0.262 1.5 (0.7–3.3)
2. Not 100 % detection 95.1 75.0 0.001* 6.2 (1.6–23.7)* 96.7 82.2 0.004* 5.6 (1.3–23.1)*
3. False-positive results 92.8 79.2 0.04* 3.4 (1.0–11.5)* 92.2 86.7 0.302 1.0 (0.6–6.3)
4. Stressful if positive 97.3 87.5 0.035* 5.6 (0.9–33.8) 98.9 88.9 0.008* 13.6 (1.5–125.5)*
5. May not be informative 74.8 58.5 0.104 2.1 (0.9-5.3) 75.6 64.4 0.176 1.6 (0.7–3.5)
*statistically significant
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More women preferred conventional screening before
NIPT to direct NIPT (57.8 % vs 30.4 %) even though
they had experience with the forme. Women were most
concerned with the cost of a screening test [29] besides
the risk of miscarriage [30]. We postulate that the differ-
ence in their preferences was related to the price differ-
ence between a ‘free’ conventional screening offered by a
public hospital and an expensive self-financed NIPT.
However, if the price of NIPT decreases to an acceptable
level in the future, women’s preference will probably
change to opting for NIPT as a primary screening.
Consistent with a previous study [28], the women’s
preference or self-risk assessment was independent of
maternal age, education or parity. Less than half of the
women replied that their information on NIPT was re-
ceived from their private doctors, while nearly half of
women learned it from the web. Self-risk assessment was
influenced largely by counselling by health-care profes-
sionals and the media apart from personal experience [28].
The web is a common way of searching for informa-
tion nowadays, but the accuracy of information on the
web is variable. No specific healthcare profession most
suited to providing counselling on NIPT has been identi-
fied. ACMG and NSGC recommend counselling by a
qualified prenatal care provider, a trained designee or a
genetic counsellor [20, 21]. In a study in U.K., women
preferred pre- and post-NIPT counselling by a midwife
[14]. In Hong Kong, trained midwives in maternal and
fetal medicine team have been providing prenatal counsel-
ling on universal conventional Down syndrome screening
to all pregnant women. This provides a good platform for
further training on NIPT counselling. Continuous educa-
tion is required to equip obstetricians and midwives with
the competences in providing such counselling [31]. In a
previous study on conventional screening tests, obstetri-
cians would prefer waiting longer and accepting a greater
decrease in detection rate for a safer test than midwives
[32]. However, another study showed no correlation be-
tween individual healthcare professionals’ attitudes and
screening uptake [33]. The determinants of the uptake
rate of a diagnostic test are patient-centred after ad-
equate counselling is provided [34].
NIPT should be offered in the context of informed de-
cision making, education, pre-test and post-test, and
counselling [18–21, 35]. In a previous study, around
72 % of women declined NIPT [35]. In the present
study, around half the women preferred conventional
screening despite a previous history of NIPT. High-risk
women electing NIPT tend to have higher scores of de-
pression/anxiety [36]. An increased level of knowledge
of prenatal screening for Down syndrome was associated
with less ambivalence and higher level of wellbeing, but
not with worries about the results [37]. The information
given should include the purpose, advantages, follow-up
invasive testing, and limitations of NIPT [20]. Despite a
risk of about 5 % of an uninformative test result of NIPT
[35], about 30 % of the women in the present study were
not aware of this possibility. Uninformative test results
could lead to a delay in diagnosis or unavailability of in-
formation for risk assessment [20]. Besides, about 30 %
of women were not aware of the limitation of NIPT in
the detection of uncommon aneuploidies compared to
an invasive test. It is important to correct false assump-
tions that might otherwise lead to these tests being de-
clined by patients [25].
A major strength of this study was that the ten know-
ledge questions in the questionnaire were designed ac-
cording to the ISPD rapid response statement [18]. It
seems that this is the first time such a questionnaire was
used to assess women’s knowledge on NIPT as far as we
know. Whether a shorter questionnaire consisting of
knowledge questions 1 to 5 is sufficient to test women’s
basic knowledge on NIPT requires further study, as
knowledge questions 6 to 10 appeared too complicated
or difficult for the women to answer. Limitations of this
pilot study are the small sample size, single centre and
exclusively Chinese population. Significant bias might
have been introduced by offering assistance by an expe-
rienced midwife to the women during completion of the
questionnaire. However, the assistance was provided in a
straightforward manner and confined to explanation of
medical terms or general terms if Cantonese was not
their mother tongue. Moreover, we did not assess
women’s knowledge on other limitations of NIPT involv-
ing turn-around time, screening for open neural tube de-
fects, anomaly, and late-pregnancy complications as
stated in the ACMG policy statement [20]. Furthermore,
we also did not assess other aspects like determination
of fetal sex, maternal DNA abnormalities [38] and pater-
nity testing [39]. In this pilot study, question 4 in Table 2
was not well constructed because it consisted of two
sentences, although we intended to pose the last part;
that is, for some women the extended period awaiting
confirmatory invasive testing results is likely to be highly
stressful. The lack of validity checking by experts, assess-
ment of applicability and reliability of the questionnaire
are limitations of this pilot study. We will further de-
velop the questionnaire in our subsequent studies.
Conclusions
It is feasible to use a questionnaire based on the ISPD
statement on NIPT to assess women’s knowledge. The
Chinese pregnant women who underwent NIPT knew
more about the false positive and false negative results
than the test accuracy in comparison to an invasive test,
and the possibility of a non-informative report, but knew
little about the more complicated aspects of NIPT. Less
than half of them received information from medical
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professionals. More information by healthcare profes-
sionals is required for an informed choice and to avoid
misunderstanding. With increasing use of NIPT in clin-
ical practice for wider indications, it is important to find
ways to keep healthcare professionals updated so that
they can provide adequate information to women before
testing. In Hong Kong, counselling on NIPT by trained
midwives with the support of obstetricians for abnormal
or difficult cases is worth further exploration. It seems
that women prefer NIPT as a contingent measure to a
primary screening test probably because of its high cost,
but this preference may change, as the costs will likely
go down in the future.
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